MarketCap
Facebook
X
TelegramPRA Health Sciences, Inc. ROCE Ratio 2011-2026 | PRAH
Annual ROCE Ratio PRA Health Sciences, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 9.75 | 14.51 | 13.87 | 11.07 | 12.79 | 9.71 | 3.21 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 14.51 | 3.21 | 10.7 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
|
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M |  USA |
 |
Brainsway Ltd.
BWAY
|
-17.75 | $ 19.02 | 0.21 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-41.81 | $ 20.15 | -2.3 % | $ 217 M |  China |
 |
Co-Diagnostics
CODX
|
-47.68 | $ 0.17 | -6.7 % | $ 4.99 M | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
Danaher Corporation
DHR
|
9.82 | $ 228.92 | -0.76 % | $ 167 B | USA |
 |
BioNano Genomics
BNGO
|
-293.94 | $ 1.53 | 2.0 % | $ 1.94 M | USA |
 |
DexCom
DXCM
|
28.89 | $ 66.37 | -1.03 % | $ 25.6 B | USA |
 |
Castle Biosciences
CSTL
|
1.9 | $ 38.9 | -1.04 % | $ 1.08 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
DarioHealth Corp.
DRIO
|
-66.97 | $ 11.38 | 6.36 % | $ 323 M | Israel |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-36.48 | $ 101.56 | -0.33 % | $ 18.8 B | USA |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 26.27 | -0.83 % | $ 794 M | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
CareDx, Inc
CDNA
|
-77.82 | $ 18.84 | -1.21 % | $ 1.01 B | USA |
 |
IQVIA Holdings
IQV
|
36.29 | $ 225.41 | -1.0 % | $ 40.9 B | USA |
 |
Celcuity
CELC
|
-97.97 | $ 99.74 | -0.18 % | $ 3.93 B | USA |
 |
Anixa Biosciences
ANIX
|
-69.16 | $ 3.12 | - | $ 99.5 K | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Guardant Health
GH
|
317.65 | $ 102.14 | 1.53 % | $ 12.5 B | USA |
 |
Aspira Women's Health
AWH
|
-486.78 | - | -6.19 % | $ 10.5 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-281.17 | $ 4.53 | -4.83 % | $ 2.43 M | USA |
 |
Myriad Genetics
MYGN
|
-17.62 | $ 6.15 | -0.32 % | $ 557 M | USA |
 |
NeoGenomics
NEO
|
-6.89 | $ 11.76 | -3.84 % | $ 1.49 B | USA |
 |
Illumina
ILMN
|
-35.1 | $ 131.16 | -1.2 % | $ 20.9 B | USA |
 |
Charles River Laboratories International
CRL
|
6.57 | $ 199.48 | -1.24 % | $ 10.2 B | USA |
 |
National Research Corporation
NRC
|
81.8 | $ 18.77 | 0.64 % | $ 461 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
19.86 | $ 173.53 | -1.12 % | $ 19.3 B | USA |
|
Biodesix
BDSX
|
-41.6 | $ 6.8 | 1.19 % | $ 882 M | USA |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
13.5 | $ 250.88 | -0.87 % | $ 21 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 182.22 | -0.43 % | $ 15 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
50.7 | $ 676.53 | -0.85 % | $ 55.8 B | USA |
 |
Lantheus Holdings
LNTH
|
42.0 | $ 66.55 | -0.91 % | $ 4.61 B | USA |
 |
Mettler-Toledo International
MTD
|
35.8 | $ 1 394.19 | -1.42 % | $ 29.6 B |  Schweiz |
 |
Precipio
PRPO
|
-52.81 | $ 22.98 | -1.84 % | $ 29.8 M | USA |
 |
Agilent Technologies
A
|
25.0 | $ 136.07 | -1.13 % | $ 41.4 B | USA |
 |
Personalis
PSNL
|
-33.64 | $ 7.96 | -0.13 % | $ 472 M | USA |
 |
Biomerica
BMRA
|
-125.14 | $ 2.52 | 2.86 % | $ 5.79 M | USA |
 |
Bioventus
BVS
|
-47.08 | $ 7.44 | -0.13 % | $ 466 M | USA |